Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Erdosteine Market

Erdosteine Market Share

Report ID: GMI3371
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Erdosteine Market Share

Companies include, Reipharm AB, Hanmi Pharmaceutical, Hikma Pharmaceuticals, Shandong Luoxin Pharmaceutical, and Zhejiang Kangle Pharmaceutical Co., Ltd have each made significant strides in the global market.

Reipharm AB is recognized for its innovation in formulation and development, enhancing the efficacy of erdosteine. Hanmi Pharmaceutical has expanded market reach through strategic partnerships and competitive pricing, positioning itself as a key player in Asia. Hikma Pharmaceuticals is notable for its robust global distribution network, ensuring widespread availability of erdosteine products. Shandong Luoxin Pharmaceutical contributes through high-quality manufacturing practices, adhering to international standards which bolster its market credibility. Zhejiang Kangle Pharmaceutical Co., Ltd has made advancements in production technology, which improves product quality and cost efficiency.

Erdosteine Market Companies

Major players operating in the erdosteine industry are:

Apotex Inc.
Cipla Ltd.
Dr. Reddy's Laboratories
Hanmi Pharmaceutical
Hikma Pharmaceuticals
Mylan N.V.
Reipharm AB
Sandoz
Shandong Luoxin Pharmaceutical
Zhejiang Kangle Pharmaceutical Co., Ltd

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The global market size for erdosteine was valued at USD 54.2 million in 2024 and is projected to reach USD 100.3 million by 2034, driven by a CAGR of over 8.1% from 2025 to 2034.

The pharmaceutical segment held a 42.9% market share in 2024, amounting to USD 21.4 million, and is projected to grow at a 7.9% CAGR from 2025 to 2034, driven by increasing technological advancements and R&D spending.

The U.S. market is projected to achieve USD 21.8 million by 2034, driven by a CAGR of 6.3% from 2025 to 2034, due to the substantial prevalence of cigarette and tobacco smoking.

Major players in the industry include Apotex Inc., Cipla Ltd., Dr. Reddys Laboratories, Hanmi Pharmaceutical, Hikma Pharmaceuticals, Mylan N.V., Reipharm AB, Sandoz, Shandong Luoxin Pharmaceutical, and Zhejiang Kangle Pharmaceutical Co., Ltd.